Pharmaceuticals
LATEST
Regulatory & Compliance
U.S. Pharma Manufacturing Gets Boost from Regulatory Relief
U.S. pharmaceutical production set to expand under regulatory relief outlined in a new Executive Order. FDA, EPA, and U.S. Army actions aim to streamline inspections, approvals, and permitting, enhancing supply chain resilience. #PharmaNews #RegulatoryRelief #SupplyChain #FDA #EPA
Read MoreMore Pharmaceuticals Articles
Pharmaceuticals
U.S. Pharma Manufacturing Gets Boost from Regulatory Relief
U.S. pharmaceutical production set to expand under regulatory relief outlined in a new Executive Order. FDA, EPA, and U.S. Army actions aim to streamline inspections, approvals, and permitting, enhancing supply chain resilience. #PharmaNews #RegulatoryRelief #SupplyChain #FDA #EPA
Read MorePharmaceuticals
New Praise, and Pressure, For the Pharma Industry
Amy Fix, partner at Barnes & Thornburg, discusses the effects of the COVID-19 pandemic on the pharmaceutical industry, including the ways that health and safety protocols have affected the R&D process, the pandemic’s impact on the patent and regulatory landscapes, and what the future of the industry may look like.
Read MorePharmaceuticals
Life Sciences Litigation Heats Up Around Patent Eligibility And Generics
Fish & Richardson patent litigator Betsy Flanagan talks about the latest trends in high-stakes patent litigation for pharmaceutical companies and the importance of fostering more teams led by women.
Read More